🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
BioVie Inc. (BIVI)
NASDAQ: BIVI · Real-Time Price · USD
0.8000
-0.1098 (-12.07%)
At close: Nov 20, 2026, 4:00 PM EST
0.9393
+0.1393 (17.41%)
After-hours: Nov 20, 2026, 7:35 PM EST

BioVie Statistics

Total Valuation

BioVie has a market cap or net worth of $8.58 million. The enterprise value is $1.10 million.

Market Cap8.58M
Enterprise Value 1.10M

Important Dates

The last earnings date was Friday, November 6, 2026, after market close.

Earnings Date Nov 6, 2026
Ex-Dividend Date n/a

Share Statistics

BioVie has 10.72 million shares outstanding. The number of shares has increased by 205.60% in one year.

Current Share Class 10.72M
Shares Outstanding 10.72M
Shares Change (YoY) +205.60%
Shares Change (QoQ) +4.35%
Owned by Insiders (%) 0.55%
Owned by Institutions (%) 16.60%
Float 10.66M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 1.21
P/TBV Ratio 1.36
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 2.40, with a Debt / Equity ratio of 0.04.

Current Ratio 2.40
Quick Ratio 1.83
Debt / Equity 0.04
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -1,363.57

Financial Efficiency

Return on equity (ROE) is -143.66% and return on invested capital (ROIC) is -89.81%.

Return on Equity (ROE) -143.66%
Return on Assets (ROA) -76.00%
Return on Invested Capital (ROIC) -89.81%
Return on Capital Employed (ROCE) -344.18%
Weighted Average Cost of Capital (WACC) 8.53%
Revenue Per Employee n/a
Profits Per Employee -$1.74M
Employee Count13
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -41.61% in the last 52 weeks. The beta is 0.80, so BioVie's price volatility has been lower than the market average.

Beta (5Y) 0.80
52-Week Price Change -41.61%
50-Day Moving Average 1.38
200-Day Moving Average 1.52
Relative Strength Index (RSI) 30.51
Average Volume (20 Days) 917,538

Short Selling Information

The latest short interest is 589,058, so 5.49% of the outstanding shares have been sold short.

Short Interest 589,058
Short Previous Month 544,444
Short % of Shares Out 5.49%
Short % of Float 5.52%
Short Ratio (days to cover) 3.27

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -23.02M
Pretax Income -22.59M
Net Income -22.59M
EBITDA -22.85M
EBIT -23.02M
Earnings Per Share (EPS) -$2.82
Full Income Statement

Balance Sheet

The company has $7.73 million in cash and $254,374 in debt, with a net cash position of $7.48 million or $0.70 per share.

Cash & Cash Equivalents 7.73M
Total Debt 254,374
Net Cash 7.48M
Net Cash Per Share $0.70
Equity (Book Value) 6.53M
Book Value Per Share 0.75
Working Capital 6.10M
Full Balance Sheet

Cash Flow

Operating Cash Flow -18.91M
Capital Expenditures n/a
Depreciation & Amortization 165,582
Net Borrowing n/a
Free Cash Flow -18.91M
FCF Per Share -$1.76
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

BioVie does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
FCF Payout Ratio n/a
Buyback Yield -205.60%
Shareholder Yield -205.60%
Earnings Yield -352.90%
FCF Yield -224.63%

Analyst Forecast

The average price target for BioVie is $5.26, which is 556.88% higher than the current price. The consensus rating is "Strong Buy".

Price Target $5.26
Price Target Difference 556.88%
Analyst Consensus Strong Buy
Analyst Count 2
Revenue Growth Forecast (3Y) n/a
EPS Growth Forecast (3Y) n/a
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a
Graham Formula Value n/a
Graham Formula Upside n/a

Stock Splits

The last stock split was on July 7, 2025. It was a reverse split with a ratio of 1:10.

Last Split Date Jul 7, 2025
Split Type Reverse
Split Ratio 1:10

Scores

Altman Z-Score n/a
Piotroski F-Score 1